Edition:
India

Zai Lab Ltd (ZLAB.OQ)

ZLAB.OQ on NASDAQ Stock Exchange Global Market

23.44USD
2:29am IST
Change (% chg)

$0.29 (+1.25%)
Prev Close
$23.15
Open
$24.00
Day's High
$24.00
Day's Low
$23.23
Volume
16,994
Avg. Vol
--
52-wk High
$35.60
52-wk Low
$20.79

Latest Key Developments (Source: Significant Developments)

Five Prime Therapeutics And Zai Lab Announce Exclusive License Agreement
Wednesday, 20 Dec 2017 

Dec 19 (Reuters) - Five Prime Therapeutics Inc ::FIVE PRIME THERAPEUTICS AND ZAI LAB ANNOUNCE EXCLUSIVE LICENSE AGREEMENT FOR FPA144 ANTI-FGFR2B ANTIBODY IN GREATER CHINA AND GLOBAL STRATEGIC DEVELOPMENT COLLABORATION.FIVE PRIME THERAPEUTICS - GRANTED ZAI LAB AN EXCLUSIVE LICENSE TO DEVELOP AND COMMERCIALIZE FPA144 IN GREATER CHINA TERRITORY​.FIVE PRIME THERAPEUTICS INC - ‍ZAI LAB WILL BE RESPONSIBLE FOR CONDUCTING PHASE 3 FIGHT TRIAL IN GREATER CHINA​.  Full Article

No consensus analysis data available.